News
News
Unlocking sleep’s role in PTSD
In a groundbreaking study, Ben Vaughn, Rho’s Chief Strategist, Biostatistics & Protocol Design, explores how sleep disturbances impact posttraumatic stress disorder (PTSD). His research sheds light on a novel treatment, TNX-102 SL, which targets sleep quality and emotional memory processing. Discover the potential breakthrough in PTSD intervention in Psychiatry Research’s article: A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder.
News
Understanding GDPR Compliance in Clinical Trials
Dive into the complexities of GDPR compliance in clinical trials in Contract Pharma’s article, Understanding GDPR Compliance in Clinical Trials, an interview with Laura Gatavs, Head of Legal Department for Rho EU. Explore the nuances of when and where GDPR applies, grasp the basics of compliance – both at company compliance level and when negotiating clinical trial agreements – and uncover essential takeaways and best practices for clinical trial sponsors.
News
Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the FDA for Approval of Tonmya™ for the Management of Fibromyalgia
Rho is thrilled to announce our unwavering support for Tonix Pharmaceuticals as they prepare to submit their New Drug Application (NDA). Serving as a dedicated partner to Tonix, we are committed to providing the necessary resources and expertise to support the next steps toward regulatory approval of Tonmya™ for the management of fibromyalgia. Our collaboration underscores our shared dedication to advancing healthcare solutions that improve patient outcomes and enhance the quality of life. We are grateful to be a part of such an exciting partnership as we continue to champion breakthrough advancements in drug development.
News
Transformation in Trials: Becky Baggett on the Science and Strategy Behind Successful Clinical Trials
Tune in to hear Becky Baggett, Rho’s Associate Vice President of Project Delivery, navigate the world of clinical trials by “unraveling the complexities and enlightening us on the crucial collaboration between the sponsor and the CRO, the importance of clinical research sites, data management, and project management. She underscores the absolute necessity of establishing solid relationships, trust, and experience in this highly controlled and regulated field.”
News
A Conversation about Parkinson’s Clinical Trials with Dr. Peter Schmidt and Dr. Mark Stacy
Dr. Peter Schmidt, PhD, and Dr. Mark Stacy, MD discuss participating in clinical trials for Parkinson’s. Dr. Schmidt, a Davis Phinney Foundation board member, is the Chief Scientific Officer for Rho, a company that supports clinical trial strategy, design, and operations and Dr. Stacy has been involved in Parkinson’s care and research for over thirty years.
News
Applied Clinical Trials and Pharmaceutical Executive Feature Rho Regulatory Experts’ Article: The EU Regulations Catching US Pharma Companies Off Guard
Rho’s Anna Pinsky, MD, PhD, Medical Director, and Elina Smirnova, Associate Director of Start Up Services Europe are featured in Applied Clinical Trials as they take a deep dive into the European regulatory landscape and share their insights on how US Sponsors can keep their European clinical trials on schedule and within budget.
News
Rho Awarded 2023 Best Places to Work
Rho has once again been chosen as a winner of Triangle Business Journal’s 2023 Best Places to Work Awards. This is the 11th year Rho has been recognized for the Triangle Business Journal’s award “a prestigious award that honors companies for creating policies and a work environment that employees value.”
One of the most rewarding aspects of this recognition is that it is driven by employee surveys, which are then tabulated and ranked by Quantum Workplace. Rho is honored and proud to receive high marks in areas such as team effectiveness, trust with co-workers, manager effectiveness and work engagements from our employees.
News
Rho Receives 2023 CRO Leadership Award
Rho received Clinical Leader and Life Science Leader’s 2023 CRO Leadership award, marking a long history as an award recipient. Forty-six CROs were evaluated on more that 20 different performance metrics. Respondents evaluated companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensures that survey responses are based on actual involvement with CROs and clear experiential data.
Rho was recognized for Exceeding Customer Expectations in Compatibility and Quality and received 4 Individual Attribute Awards in Data Quality, Technology for Real Time Access to Data, Therapeutic Expertise and Operational Excellence.